José Ángel Arranz Arija

1 article listing José Ángel Arranz Arija in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial Nature Communications